Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

691 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of preventive drugs for cisplatin-induced acute kidney injury using big data analysis.
Kanda M, Goda M, Maegawa A, Yoshioka T, Yoshida A, Miyata K, Aizawa F, Niimura T, Hamano H, Okada N, Sakurada T, Chuma M, Yagi K, Izawa-Ishizawa Y, Yanagawa H, Zamami Y, Ishizawa K. Kanda M, et al. Among authors: sakurada t. Clin Transl Sci. 2022 Jul;15(7):1664-1675. doi: 10.1111/cts.13282. Epub 2022 Apr 30. Clin Transl Sci. 2022. PMID: 35445533 Free PMC article.
Angiotensin II receptor blocker improves tumor necrosis factor-α-induced cytotoxicity via antioxidative effect in human glomerular endothelial cells.
Izawa-Ishizawa Y, Ishizawa K, Sakurada T, Imanishi M, Miyamoto L, Fujii S, Taira H, Kihira Y, Ikeda Y, Hamano S, Tomita S, Tsuchiya K, Tamaki T. Izawa-Ishizawa Y, et al. Among authors: sakurada t. Pharmacology. 2012;90(5-6):324-31. doi: 10.1159/000343244. Epub 2012 Oct 9. Pharmacology. 2012. PMID: 23052181
Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects.
Sakurada T, Ishizawa K, Imanishi M, Izawa-Ishizawa Y, Fujii S, Tominaga E, Tsuneishi T, Horinouchi Y, Kihira Y, Ikeda Y, Tomita S, Aihara K, Minakuchi K, Tsuchiya K, Tamaki T. Sakurada T, et al. Naunyn Schmiedebergs Arch Pharmacol. 2013 Jan;386(1):29-39. doi: 10.1007/s00210-012-0810-7. Epub 2012 Nov 14. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23149861
Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects.
Ishizawa K, Izawa-Ishizawa Y, Yamano N, Urushihara M, Sakurada T, Imanishi M, Fujii S, Nuno A, Miyamoto L, Kihira Y, Ikeda Y, Kagami S, Kobori H, Tsuchiya K, Tamaki T. Ishizawa K, et al. Among authors: sakurada t. PLoS One. 2014 Jan 28;9(1):e86335. doi: 10.1371/journal.pone.0086335. eCollection 2014. PLoS One. 2014. PMID: 24489716 Free PMC article.
[Drug development for cardiorenal disease based on oxidative stress control].
Imanishi M, Ishizawa K, Sakurada T, Ishizawa Y, Yamano N, Kihira Y, Ikeda Y, Tsuchiya K, Tamaki T. Imanishi M, et al. Among authors: sakurada t. Yakugaku Zasshi. 2014;134(6):715-9. doi: 10.1248/yakushi.13-00255-4. Yakugaku Zasshi. 2014. PMID: 24882646 Free article. Review. Japanese.
Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids.
Sakurada T, Kakiuchi S, Tajima S, Horinouchi Y, Konaka K, Okada N, Nishisako H, Nakamura T, Teraoka K, Kawazoe K, Yanagawa H, Nishioka Y, Ishizawa K. Sakurada T, et al. Biol Pharm Bull. 2015;38(11):1752-6. doi: 10.1248/bpb.b15-00435. Biol Pharm Bull. 2015. PMID: 26521826 Free article.
Nitrosonifedipine, a Photodegradation Product of Nifedipine, Suppresses Pharmacologically Induced Aortic Aneurysm Formation.
Imanishi M, Izawa-Ishizawa Y, Sakurada T, Kohara Y, Horinouchi Y, Sairyo E, Zamami Y, Takechi K, Chuma M, Fukushima K, Ikeda Y, Fujino H, Yoshizumi M, Tsuchiya K, Tamaki T, Ishizawa K. Imanishi M, et al. Among authors: sakurada t. Pharmacology. 2018;102(5-6):287-299. doi: 10.1159/000492577. Epub 2018 Sep 25. Pharmacology. 2018. PMID: 30253416
691 results